Published in Brain Res on January 24, 2008
Metallothionein and brain inflammation. J Biol Inorg Chem (2011) 0.90
Unchanged survival rates of Shadoo knockout mice after infection with mouse-adapted scrapie. Prion (2014) 0.77
Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci (2012) 2.01
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies. J Exp Med (2013) 1.88
AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise. Biochem Biophys Res Commun (2004) 1.75
PGC-1alpha is not mandatory for exercise- and training-induced adaptive gene responses in mouse skeletal muscle. Am J Physiol Endocrinol Metab (2007) 1.71
New preservation strategies for preventing liver grafts against cold ischemia reperfusion injury. J Gastroenterol Hepatol (2007) 1.58
Interleukin-6 regulation of AMP-activated protein kinase. Potential role in the systemic response to exercise and prevention of the metabolic syndrome. Diabetes (2006) 1.44
Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy. J Clin Invest (2013) 1.44
Retracted Interleukin-6 receptor expression in contracting human skeletal muscle: regulating role of IL-6. FASEB J (2005) 1.39
The role of PGC-1alpha on mitochondrial function and apoptotic susceptibility in muscle. Am J Physiol Cell Physiol (2009) 1.36
Neurodegeneration and functional impairments associated with glycogen synthase accumulation in a mouse model of Lafora disease. EMBO Mol Med (2011) 1.24
PGC-1alpha mediates exercise-induced skeletal muscle VEGF expression in mice. Am J Physiol Endocrinol Metab (2009) 1.20
Astrocyte-targeted expression of IL-6 protects the CNS against a focal brain injury. Exp Neurol (2003) 1.16
Metallothionein in the central nervous system: Roles in protection, regeneration and cognition. Neurotoxicology (2008) 1.15
Hypoxic preconditioning induces neuroprotective stanniocalcin-1 in brain via IL-6 signaling. Stroke (2007) 1.13
Trans-signaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain. J Neurosci (2014) 1.10
Metallothionein isoform 2A expression is inducible and protects against ROS-mediated cell death in rotenone-treated HeLa cells. Biochem J (2006) 1.08
Metallothionein reduces central nervous system inflammation, neurodegeneration, and cell death following kainic acid-induced epileptic seizures. J Neurosci Res (2005) 1.08
Site-specific production of IL-6 in the central nervous system retargets and enhances the inflammatory response in experimental autoimmune encephalomyelitis. J Immunol (2009) 1.07
GWAS replication study confirms the association of PDE3A-SLCO1C1 with anti-TNF therapy response in rheumatoid arthritis. Pharmacogenomics (2013) 1.06
Redefining the role of metallothionein within the injured brain: extracellular metallothioneins play an important role in the astrocyte-neuron response to injury. J Biol Chem (2008) 1.03
Role of PGC-1α in exercise and fasting-induced adaptations in mouse liver. Am J Physiol Regul Integr Comp Physiol (2011) 1.01
Astrocyte-specific deficiency of interleukin-6 and its receptor reveal specific roles in survival, body weight and behavior. Brain Behav Immun (2012) 1.01
Bovine spongiform encephalopathy induces misfolding of alleged prion-resistant species cellular prion protein without altering its pathobiological features. J Neurosci (2013) 0.98
Altered distribution of RhoA in Alzheimer's disease and AbetaPP overexpressing mice. J Alzheimers Dis (2010) 0.98
Overexpression of the CHRNA5/A3/B4 genomic cluster in mice increases the sensitivity to nicotine and modifies its reinforcing effects. Amino Acids (2011) 0.96
Metallothionein-1+2 protect the CNS after a focal brain injury. Exp Neurol (2002) 0.96
A diet enriched in polyphenols and polyunsaturated fatty acids, LMN diet, induces neurogenesis in the subventricular zone and hippocampus of adult mouse brain. J Alzheimers Dis (2009) 0.96
Risk variants for psoriasis vulgaris in a large case-control collection and association with clinical subphenotypes. Hum Mol Genet (2012) 0.95
Mapping of aggrecan, hyaluronic acid, heparan sulphate proteoglycans and aquaporin 4 in the central nervous system of the mouse. J Chem Neuroanat (2007) 0.94
Thr-90 plays a vital role in the structure and function of bacteriorhodopsin. J Biol Chem (2004) 0.94
Retracted Metallothionein-mediated antioxidant defense system and its response to exercise training are impaired in human type 2 diabetes. Diabetes (2005) 0.93
Brain response to traumatic brain injury in wild-type and interleukin-6 knockout mice: a microarray analysis. J Neurochem (2005) 0.93
Heat shock proteins and mitogen-activated protein kinases in steatotic livers undergoing ischemia-reperfusion: some answers. Am J Pathol (2006) 0.92
Exercise normalises overexpression of TNF-alpha in knockout mice. Biochem Biophys Res Commun (2004) 0.92
Morphofunctional changes underlying intestinal dysmotility in diabetic RIP-I/hIFNβ transgenic mice. Int J Exp Pathol (2011) 0.91
Increased expression of water channel aquaporin 1 and aquaporin 4 in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP transgenic mice. Acta Neuropathol (2006) 0.91
Astrocyte-targeted expression of interleukin-6 protects the central nervous system during neuroglial degeneration induced by 6-aminonicotinamide. J Neurosci Res (2003) 0.91
Treatment with metallothionein prevents demyelination and axonal damage and increases oligodendrocyte precursors and tissue repair during experimental autoimmune encephalomyelitis. J Neurosci Res (2003) 0.91
Metallothionein and brain inflammation. J Biol Inorg Chem (2011) 0.90
A genome-wide association study on a southern European population identifies a new Crohn's disease susceptibility locus at RBX1-EP300. Gut (2012) 0.90
Exercise-induced liver chemokine CXCL-1 expression is linked to muscle-derived interleukin-6 expression. J Physiol (2011) 0.90
Activation of caspase-8 by tumour necrosis factor receptor 1 is necessary for caspase-3 activation and apoptosis in oxygen-glucose deprived cultured cortical cells. Neurobiol Dis (2009) 0.90
Differential role of tumor necrosis factor receptors in mouse brain inflammatory responses in cryolesion brain injury. J Neurosci Res (2005) 0.90
Gene expression profiling and association with prion-related lesions in the medulla oblongata of symptomatic natural scrapie animals. PLoS One (2011) 0.87
Generalization of DNA microarray dispersion properties: microarray equivalent of t-distribution. Biol Direct (2006) 0.86
Cyclic GMP phosphodiesterase inhibition alters the glial inflammatory response, reduces oxidative stress and cell death and increases angiogenesis following focal brain injury. J Neurochem (2009) 0.86
FDG PET imaging of Ela1-myc mice reveals major biological differences between pancreatic acinar and ductal tumours. Eur J Nucl Med Mol Imaging (2009) 0.86
Metallothionein-I overexpression decreases brain pathology in transgenic mice with astrocyte-targeted expression of interleukin-6. J Neuropathol Exp Neurol (2003) 0.86
Diverging mechanisms for TNF-alpha receptors in normal mouse brains and in functional recovery after injury: From gene to behavior. J Neurosci Res (2007) 0.85
LMN diet, rich in polyphenols and polyunsaturated fatty acids, improves mouse cognitive decline associated with aging and Alzheimer's disease. Behav Brain Res (2011) 0.85
Silent information regulator 1 protects the liver against ischemia-reperfusion injury: implications in steatotic liver ischemic preconditioning. Transpl Int (2014) 0.85
Oxidative and nitrosative stress in acute pancreatitis. Modulation by pentoxifylline and oxypurinol. Biochem Pharmacol (2011) 0.84
Metallothioneins I/II are involved in the neuroprotective effect of sildenafil in focal brain injury. Neurochem Int (2012) 0.84
Interferon-gamma regulates oxidative stress during experimental autoimmune encephalomyelitis. Exp Neurol (2002) 0.84
Genome-wide transcriptional analysis of T cell activation reveals differential gene expression associated with psoriasis. BMC Genomics (2013) 0.84
Interleukin-18 activates skeletal muscle AMPK and reduces weight gain and insulin resistance in mice. Diabetes (2013) 0.84
Effect of astrocyte-targeted production of IL-6 on traumatic brain injury and its impact on the cortical transcriptome. Dev Neurobiol (2008) 0.84
Characterization of the role of the antioxidant proteins metallothioneins 1 and 2 in an animal model of Alzheimer's disease. Cell Mol Life Sci (2012) 0.83
Specificity and divergence in the neurobiologic effects of different metallothioneins after brain injury. J Neurosci Res (2006) 0.83
Role of metallothionein-III following central nervous system damage. Neurobiol Dis (2003) 0.83
Differential expression and protein distribution of Bax in natural scrapie. Brain Res (2007) 0.83
Metallothionein 1+2 protect the CNS during neuroglial degeneration induced by 6-aminonicotinamide. J Comp Neurol (2002) 0.83
CNstream: a method for the identification and genotyping of copy number polymorphisms using Illumina microarrays. BMC Bioinformatics (2010) 0.83
Sildenafil (Viagra) ameliorates clinical symptoms and neuropathology in a mouse model of multiple sclerosis. Acta Neuropathol (2011) 0.83
Metallothionein and stress combine to affect multiple organ systems. Cell Stress Chaperones (2014) 0.83
Molecular imaging coupled to pattern recognition distinguishes response to temozolomide in preclinical glioblastoma. NMR Biomed (2014) 0.82
Improving the classification of brain tumors in mice with perturbation enhanced (PE)-MRSI. Integr Biol (Camb) (2011) 0.82
Metallothionein prevents neurodegeneration and central nervous system cell death after treatment with gliotoxin 6-aminonicotinamide. J Neurosci Res (2004) 0.82
Dural tear and myelomalacia caused by an airgun pellet in a cat. Can Vet J (2013) 0.82
Metallothionein-1+2 deficiency increases brain pathology in transgenic mice with astrocyte-targeted expression of interleukin 6. Neurobiol Dis (2002) 0.81
Immunohistochemical localization of the sigma1 receptor in Schwann cells of rat sciatic nerve. Brain Res (2004) 0.81
Retracted Exercise-induced metallothionein expression in human skeletal muscle fibres. Exp Physiol (2005) 0.81
Focus: a robust workflow for one-dimensional NMR spectral analysis. Anal Chem (2013) 0.81
Analysis of the cerebral transcriptome in mice subjected to traumatic brain injury: importance of IL-6. Neuroimmunomodulation (2007) 0.81
Anti-apoptotic effect of Mao-B inhibitor PF9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] is mediated by p53 pathway inhibition in MPP+-treated SH-SY5Y human dopaminergic cells. J Neurochem (2008) 0.80
Imaging diagnosis--Spinal epidural hemangiosarcoma in a dog. Vet Radiol Ultrasound (2013) 0.80
Induction of atypical EAE mediated by transgenic production of IL-6 in astrocytes in the absence of systemic IL-6. Glia (2013) 0.80
Improved rat steatotic and nonsteatotic liver preservation by the addition of epidermal growth factor and insulin-like growth factor-I to University of Wisconsin solution. Liver Transpl (2010) 0.80
Cyclic adenosine 3',5'-monophosphate in rat steatotic liver transplantation. Liver Transpl (2011) 0.80
Convex non-negative matrix factorization for brain tumor delimitation from MRSI data. PLoS One (2012) 0.80
Minimization of spectral pattern changes during HRMAS experiments at 37 degrees celsius by prior focused microwave irradiation. MAGMA (2012) 0.79
Characterisation of Lafora-like bodies and other polyglucosan bodies in two aged dogs with neurological disease. Vet J (2008) 0.79
Central nervous system extracellular matrix changes in a transgenic mouse model of bovine spongiform encephalopathy. Vet J (2008) 0.79
Characterization of the role of metallothionein-3 in an animal model of Alzheimer's disease. Cell Mol Life Sci (2012) 0.79
Retracted M-CSF deficiency leads to reduced metallothioneins I and II expression and increased tissue damage in the brain stem after 6-aminonicotinamide treatment. Exp Neurol (2002) 0.79
Detection of Neospora caninum tachyzoites in canine cerebrospinal fluid. J Vet Intern Med (2006) 0.79
Aquaporin 1 and aquaporin 4 overexpression in bovine spongiform encephalopathy in a transgenic murine model and in cattle field cases. Brain Res (2007) 0.79
Diabetic neuropathy: electrophysiological and morphological study of peripheral nerve degeneration and regeneration in transgenic mice that express IFNbeta in beta cells. Muscle Nerve (2010) 0.79
Stress response in the central nervous system of a transgenic mouse model of bovine spongiform encephalopathy. Vet J (2007) 0.79
Central nervous system gene expression changes in a transgenic mouse model for bovine spongiform encephalopathy. Vet Res (2011) 0.79
Leishmania amastigotes in the central nervous system of a naturally infected dog. J Vet Diagn Invest (2012) 0.79
Effects of astrocyte-targeted production of interleukin-6 in the mouse on the host response to nerve injury. Glia (2014) 0.78
Imaging diagnosis-magnetic resonance imaging findings of an intracranial epidural tuberculoma in a dog. Vet Radiol Ultrasound (2012) 0.78
Assessment of calcium-binding proteins (Parvalbumin and Calbindin D-28K) and perineuronal nets in normal and scrapie-affected adult sheep brains. J Virol Methods (2006) 0.78